This Next-Gen Obesity Drug: Can It Save Novo Nordisk?
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Risk parity assigns capital to balance risk contributions across asset classes in retirement portfolios, aiming for steadier, more resilient returns.
26,821 articlesNovo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
House Democrats introduced the Death Bets Act to outlaw prediction markets tied to war outcomes and fatalities amid o...
Tesla faced a rocky period, but a few hopeful indicators suggest the EV leader may be on a steadier path. This articl...
UniCredit announces a $40 billion bid for Germany’s second-largest bank with a 4% premium, but early signals point to...
Tempo, a Layer 1 blockchain backed by Stripe, has officially launched its mainnet with a sharp focus on AI agent paym...
I recently allocated just more than $10,000 across three tech stocks to balance growth with risk. Here’s how I chose ...
A Tokyo-based lender is weighing a potential Jefferies takeover, a move that could reshape cross-border banking and i...
Is intuitive surgical right now? The robotics leader faces macro headwinds and strong long term demand. This guide br...
ETH failed to clear $2,400, hinting at a pullback toward the $2,000 zone. XRP lingers inside a pennant below $1.40, w...
U.S. stock futures fall as oil surges after President Trump labeled Iran’s response to a ceasefire offer as 'totally ...
A sharp one-day drop in ZoomInfo’s shares has investors weighing growth against profitability. This analysis explains...
Two data-focused tech players, Palantir and BigBear.ai, report quarterly numbers that investors watch closely. This g...